Enhancing immune responses using suicidal DNA vaccines
Abstract
We describe a DNA vaccine strategy that allows antigens to be produced in vivo in the context of an alphaviral replicon. Mice immunized with such vectors developed humoral and cellular immune responses at higher levels than mice that received a conventional DNA vaccine vector. Immunized animals acquired protective immunity to lethal influenza challenge. Compared with traditional DNA vaccine strategies in which vectors are persistent and the expression constitutive, the expression mediated by the alphaviral vector was transient and lytic. As a result, biosafety risks such as chromosomal integration, and the induction of immunological tolerance, could be circumvented.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Introduction of repRNA into cells initiates ongoing biosynthesis of antigen-encoding RNA that results in dramatically increased expression and duration that enhances humoral and cellular immune responses.
“introduction of repRNA into cells initiates ongoing biosynthesis of antigen-encoding RNA that results in dramatically increased expression and duration that enhances humoral and cellular immune responses (27).”
From An <i>Alphavirus</i> -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020) · cites this paper as [27]
Cites
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · see citing works
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318 · see citing works
Genetic immunization is a simple method for eliciting an immune response
Tang, D.-C. C., DeVit, M. J., & Johnston, S. A. (1992) · Nature · doi:10.1038/356152a0 · Cited by 1,504 · see citing works
Taswell, C. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1614 · Cited by 1,249 · see citing works
Donnelly, J., Ulmer, J. B., Shiver, J. W., & Liu, M. A. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.617 · Cited by 985 · see citing works
A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus Replicon
Liljeström, P., & Garoff, H. (1991) · Nature Biotechnology · doi:10.1038/nbt1291-1356 · Cited by 905 · see citing works
Self-citationIsolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J. W., Jung, G., & Rammensee, H. (1990) · Nature · doi:10.1038/348252a0 · Cited by 771 · see citing works
Long-term persistence of plasmid DNA and foreign gone expression in mouse muscle
Wolff, J. A., Ludtke, J. J., Acsádi, G., Williams, P. M., & Jáni, Á. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.363 · Cited by 739 · see citing works
Raz, E., Carson, D. A., Parker, S. E., Parr, T. B., Abai, A. M., Aichinger, G., Gromkowski, S. H., Singh, M., Lew, D., & Yankauckas, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9519 · Cited by 543 · see citing works
Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene
Levine, B., Huang, Q. R., Isaacs, J. T., Reed, J. C., Griffin, D. E., & Hardwick, J. M. (1993) · Nature · doi:10.1038/361739a0 · Cited by 489 · see citing works
Pushko, P., Parker, M., Ludwig, G. V., Davis, N., Johnston, R. E., & Smith, J. (1997) · Virology · doi:10.1006/viro.1997.8878 · Cited by 444 · see citing works
Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J. H., Rundell, A., Margalith, M., & Dwarki, V. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-419 · Cited by 432 · see citing works
Robinson, H. L., Hunt, L., & Webster, R. G. (1993) · Vaccine · doi:10.1016/0264-410x(93)90385-b · Cited by 428 · see citing works
Davis, H. L., Michel, M., & Whalen, R. G. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.11.1847 · Cited by 401 · see citing works
Xiang, Z., Spitalnik, S. L., Tran, M., Wunner, W. H., Cheng, J., & Ertl, H. C. J. (1994) · Virology · doi:10.1006/viro.1994.1105 · Cited by 390 · see citing works
Letvin, N. L., Montefiori, D. C., Yasutomi, Y., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9378 · Cited by 313 · see citing works
Semliki Forest Virus Expression System: Production of Conditionally Infectious Recombinant Particles
Berglund, P., Sjöberg, M., Garoff, H., Atkins, G. J., Sheahan, B. J., & Liljeström, P. (1993) · Nature Biotechnology · doi:10.1038/nbt0893-916 · Cited by 289 · see citing works
Self-citationPotential DNA Vaccine Integration into Host Cell Genome
Nichols, W. W., Ledwith, B. J., Manam, S., & Troilo, P. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44729.x · Cited by 268 · see citing works
The role of CpG dinucleotides in DNA vaccines
Krieg, A. Μ., Yi, A., Schorr, J., & Davis, H. L. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01145-1 · Cited by 247 · see citing works
Levels of Peripheral T Cell Tolerance Induced by Different Doses of Tolerogen
Ferber, I., Schönrich, G., Schenkel, J., et al. (1994) · Science · doi:10.1126/science.8303275 · Cited by 230 · see citing works
Self-replicating Semliki Forest virus RNA as recombinant vaccine
Zhou, X., Berglund, P., Rhodes, G., Parker, S. E., Jondal, M., & Liljeström, P. (1994) · Vaccine · doi:10.1016/0264-410x(94)90074-4 · Cited by 193 · see citing works
Self-citationSindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer
Dubensky, T. W., Driver, D. A., Polo, J. M., Belli, B., LATHAM, E. M., Ibañez, C. E., Chada, S., Brumm, D., Banks, T. A., Mento, S. J., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.508-519.1996 · Cited by 192 · see citing works
DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector
Hariharan, M. J., Driver, D. A., Townsend, K., Brumm, D., Polo, J. M., Belli, B., Catton, D. J., Hsu, D. S., Mittelstaedt, D., McCormack, J. E., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.950-958.1998 · Cited by 178 · see citing works
Frolov, I. V., & Schlesinger, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1721-1727.1994 · Cited by 147 · see citing works
Donnelly, J., Ulmer, J. B., & Liu, M. A. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00502-4 · Cited by 140 · see citing works
Fu, T., Friedman, A., Ulmer, J. B., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2715-2721.1997 · Cited by 130 · see citing works
Induction of neonatal tolerance by plasmid DNA vaccination of mice.
Mor, G., Yamshchikov, G. V., Sedegah, M., Takeno, M., Wang, R., Houghten, R. A., Hoffman, S. L., & Klinman, D. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119094 · Cited by 130 · see citing works
Sjöberg, M., Suomalainen, M., & Garoff, H. (1994) · Nature Biotechnology · doi:10.1038/nbt1194-1127 · Cited by 130 · see citing works
Zhou, X., Berglund, P., Zhao, H., Liljeström, P., & Jondal, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3009 · Cited by 115 · see citing works
Self-citationDavis, N., Brown, K. W., & Johnston, R. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3781-3787.1996 · Cited by 111 · see citing works
Zarozinski, C. C., Fynan, E. F., Selin, L. K., Robinson, H. L., & Welsh, R. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.4010 · Cited by 109 · see citing works
A Plasmid-Based Self-Amplifying Sindbis Virus Vector
Herweijer, H., Latendresse, J. S., Williams, P., Zhang, G., Dankó, I., Schlesinger, S., & Wolff, J. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.9-1161 · Cited by 95 · see citing works
Death mechanisms in cultured cells infected by Semliki Forest virus.
Glasgow, G. M., Atkins, G. J., Gee, M. M. M., et al. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-7-1559 · Cited by 92 · see citing works
RAMPAGE: Promoter Activity Profiling by Paired-End Sequencing of 5′-Complete cDNAs
Batut, P. J., & Gingeras, T. (2013) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb25b11s104 · Cited by 79 · see citing works
Alphavirus expression vectors and their use as recombinant vaccines: a minireview
Tubulekas, I., Berglund, P., Fleeton, M. N., & Liljeström, P. (1997) · Gene · doi:10.1016/s0378-1119(96)00679-8 · Cited by 67 · see citing works
Self-citationExpression of Proteins Using Semliki Forest Virus Vectors
Liljeström, P., & Garoff, H. (1995) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1620s29 · Cited by 55 · see citing works
Self-citationLong life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance
Alferink, J., Schittek, B., Schönrich, G., et al. (1995) · International Immunology · doi:10.1093/intimm/7.2.331 · Cited by 53 · see citing works
The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice.
Gates, M., Sheahan, B., & Atkins, G. (1984) · Journal of General Virology · doi:10.1099/0022-1317-65-1-73 · Cited by 39 · see citing works
Neurogenic spread of Semliki forest virus in mice
Kaluza, G., Lell, G., Reinacher, M., et al. (1987) · Archives of Virology · doi:10.1007/bf01313896 · Cited by 31 · see citing works
Zhang, J., Asselin‐Paturel, C., Bex, F., et al. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300409 · Cited by 31 · see citing works
Long-term effects of Semliki Forest virus infection in the mouse central nervous system.
Donnelly, S., Sheahan, B. J., & Atkins, G. J. (1997) · PubMed · Cited by 29 · see citing works
Long‐term effects of Semliki Forest virus infection in the mouse central nervous system
Donnelly, S., Sheahan, B. J., & Atkins, G. J. (1997) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1997.tb01207.x · Cited by 24 · see citing works
Expression of IFN A genes in subpopulations of peripheral blood cells
Brandt, E. R., Linnane, A. W., & Devenish, R. J. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04820.x · Cited by 23 · see citing works
Robinson, H. L., LU, S., Feltquate, D., et al. (1996) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1996.12.455 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Erasmus, J. H., Khandhar, A. P., O’Connor, M. A., Walls, A. C., Hemann, E. A., Murapa, P., Archer, J., Leventhal, S., Fuller, J. T., Lewis, T. B., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc9396 · Cited by 241 · see citing works
Self-citationAlphavirus vectors and vaccination
Rayner, J. O., Dryga, S. A., & Kamrud, K. I. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.360 · Cited by 181 · see citing works
Fleeton, M. N., Chen, M., Berglund, P., Rhodes, G., Parker, S. E., Murphy, M., Atkins, G. J., & Liljeström, P. (2001) · The Journal of Infectious Diseases · doi:10.1086/319857 · Cited by 157 · see citing works
Self-citationAmplifying RNA Vaccine Development
Fuller, D. H., & Berglund, P. (2020) · New England Journal of Medicine · doi:10.1056/nejmcibr2009737 · Cited by 116 · see citing works
Self-citationIntradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
Johansson, D. X., Ljungberg, K., Kakoulidou, M., & Liljeström, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029732 · Cited by 98 · see citing works
Self-citationRise of the RNA machines – self-amplification in mRNA vaccine design
Comes, J. D. G., Pijlman, G. P., & Hick, T. A. H. (2023) · Trends in Biotechnology · doi:10.1016/j.tibtech.2023.05.007 · Cited by 87 · see citing works
- Authors
- Berglund, P., Smerdou, C., Fleeton, M. N., Tubulekas, L., & Liljeström, P.
- Affiliations
- Karolinska Institutet (SE)
- Swedish Institute (SE)
- Corresponding author
- Liljeström, Peter
- Venue
- Nature Biotechnology
- Published
- 1998-06
- Volume
- 16
- Issue
- 6
- Pages
- 562-565
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1998667730
- Cited by
- 229
- References
- 44
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 1 · 2015: 7 · 2014: 14 · 2013: 8 · 2012: 9
- FWCI
- 19.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- DNA vaccine, humoral immune response, cell-mediated immunity, influenza vaccination, protective immunity, chromosomal integration, immune tolerance, biosafety
- MeSH terms
- Adjuvants, Immunologic, Animals, Antibody Formation, Cell Line, Cytopathogenic Effect, Viral, DNA, Recombinant, Female, Genetic Vectors, Cricetinae, Immunity, Cellular, Kidney, Mice, Inbred BALB C, Mice, Inbred C57BL, Orthomyxoviridae Infections, Influenza A virus, Replicon, Semliki forest virus, Gene Expression Regulation, Viral, Vaccines, DNA, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review